Phase II clinical trials revealed that the lymphocyte-depleting humanized monoclonal
antibody alemtuzumab (Campath-1H) is highly effective in the treatment of early relapsing-…

Abstract Treatment of early relapsing–remitting multiple sclerosis with the lymphocyte-depleting
humanized monoclonal antibody alemtuzumab (Campath [registered trade mark]) …

Background and Purpose— Acute leukocytosis is a well-established response to intracerebral
hemorrhage (ICH). Leukocytes, because of their interaction with platelets and coagulation …

Acute ischemic stroke affects men and women differently. In particular, women are often
reported to experience higher acute stroke severity than men. We derived a low-dimensional …

Importance Calcium is a key cofactor of the coagulation cascade and may play a role in the
pathophysiology of intracerebral hemorrhage (ICH). Objective To investigate whether a low …

Background and Objectives Topographical distribution of white matter hyperintensities (WMH)
are hypothesized to vary by cerebrovascular risk factors. We used an unbiased pattern …

Rationale: Ischemic stroke is among the leading causes of adult disability. Part of the variability
in functional outcome after stroke has been attributed to genetic factors but no locus has …

Background and Purpose— Volumes of hemorrhage and perihematomal edema (PHE) are
well-established biomarkers of primary and secondary injury, respectively, in spontaneous …

Objective Observational studies point to an inverse correlation between low‐density
lipoprotein (LDL) cholesterol levels and risk of intracerebral hemorrhage (ICH), but it remains …

Objective Endothelial dysfunction is an early and prevalent pathology in Alzheimer disease (AD).
We here investigate the value of vascular endothelial‐cadherin (VEC) as a …